Drug Shortage Report for MYLAN-GALANTAMINE ER
Report ID | 209416 |
Drug Identification Number | 02339439 |
Brand name | MYLAN-GALANTAMINE ER |
Common or Proper name | GALANTAMINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | GALANTAMINE |
Strength(s) | 8MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 30BT, 100BT |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-12-11 |
Actual start date | 2023-12-18 |
Estimated end date | 2024-03-19 |
Actual end date | 2024-03-19 |
Shortage status | Resolved |
Updated date | 2024-03-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2024-03-25 | French | Compare |
v17 | 2024-03-25 | English | Compare |
v16 | 2024-03-06 | French | Compare |
v15 | 2024-03-06 | English | Compare |
v14 | 2024-02-28 | French | Compare |
v13 | 2024-02-28 | English | Compare |
v12 | 2024-01-30 | French | Compare |
v11 | 2024-01-30 | English | Compare |
v10 | 2024-01-10 | French | Compare |
v9 | 2024-01-10 | English | Compare |
v8 | 2023-12-19 | French | Compare |
v7 | 2023-12-19 | English | Compare |
v6 | 2023-12-13 | French | Compare |
v5 | 2023-12-13 | English | Compare |
v4 | 2023-12-13 | French | Compare |
v3 | 2023-12-13 | English | Compare |
v2 | 2023-11-06 | French | Compare |
v1 | 2023-11-06 | English | Compare |
Showing 1 to 18 of 18